Craig Dahl

Controller at FLG Partners

Craig Dahl has a diverse background in finance and accounting. Craig started their career as a Consultant at LiveRamp, where they helped with year-end accounting and supported a Big 4 audit. Craig then worked as a Consultant at Evolv, Inc., where they assisted with a two-year audit and implemented Shareworks software. Craig also served as a Board Member at Softech and as a Consulting Controller at Visionnaire Ventures.

In 2013, Craig became the Controller at Profit Velocity Solutions, a software company with offices in the US and Singapore. Craig later joined FLG Partners, LLC as a Controller and helped with various financial responsibilities.

Craig also has experience in the pharmaceutical industry. Craig worked as a Controller at Spruce Biosciences and played a role in the development of neuro/endocrine applications. Craig was also the Controller at Oyster Point Pharmaceuticals, where they contributed to the successful IPO of the company. Additionally, Craig served as a Controller at Tunitas Therapeutics, a biotech company focused on developing protein therapeutics for allergy sufferers.

Overall, Craig Dahl has a strong finance and accounting background and has worked with various companies in different industries, including technology, biotech, and pharmaceuticals.

Craig Dahl attended Santa Clara University Leavey School of Business from 1977 to 1979, where they obtained an MBA degree in Finance. Prior to that, from 1975 to 1977, they studied Biological Science at the University of California, Davis and received a BA degree. Additionally, Craig Dahl holds a CPA certification awarded by the state of California. The exact month and year of obtaining this certification are not provided.

Links

Previous companies

Spruce Biosciences logo

Org chart

No direct reports

Timeline

  • Controller

    January, 2012 - present